increased in revenues from sales of medicated pet shampoo, pet foods products, livestock animal products, and revenues from sales of wellness & anti-aging products and aesthetic innovations products. 2. Cost

growth was driven primarily by an increase in revenues from sales of pet skincare shampoo products, pet food products and livestock animal products, and revenues from sales of wellness & anti-ageing

% MB % MB % 1. Wellness and Anti-aging 128.58 40.58% 162.70 43.82% 34.12 26.54% 2. Aesthetic Innovation 96.00 30.30% 67.17 18.09% (28.83) (30.03%) 3. Companion Animal Health 80.78 25.50% 132.19 35.60

-634-0225 Fax 02-634-0135 www.interpharma.co.th Type of Revenue 1st Quarter 2020 1st Quarter 2019 Change MB % MB % MB % 1. Wellness & Anti-Aging 47.77 49.18 31.87 37.52 15.90 49.90% 2. Aesthetic

Company has to recognize loss from allowance goodwill and intangible assets (international expansion) from the beauty business of THB 1,858 million. The consolidated loss of YE 2017 is THB 2,415 million

to recognize loss from allowance goodwill and intangible assets (international expansion) from the beauty business of THB 1,858 million. The consolidated loss of YE 2017 is THB 2,415 million

administrative expense to support business expansion. Without the non-recurring profit related to sale of Dusit Princess Korat, core EBITDA was THB 806 million, a 12.3% decrease from 2016. The Company reported net

leveraging on scale and value-added services Fixed broadband revenue reached Bt7,437mn, a strong growth of 146% YoY and 2.1% QoQ. This growth is driven by high-quality subscriber expansion, a robust nationwide

growth in all major segments together with gross margin expansion. - Q1’20 Revenue from sales grew by 5.0% YoY, amounting to THB 6.7 billion, driven by the growth in all major segments particulary

benefits from the business expansion. In addition, the Company has continued our strategic projects, including the mixed-use project ‘Dusit Central Park’ as planned. Major Developments Hotel Business At the